Safety

VetStem Regenerative Cells – Key Safety Factors:

• Autologous (from the patient back to the same patient): Tissue reaction risk is minimized
• Minimally manipulated: Cells are not differentiated or modified
• Accurate determination of each dose
• Quality assessment of each dose
• VetStem employs stringent processing protocols and quality control methods
• Hundreds of publications support the safety of autologous cell therapy in animals
• Reported canine adverse reaction rate is 0.1%
• Reported equine adverse reaction rate is 0.2%
• Reported feline adverse reaction rate is 0.3%

Pet owners should discuss appropriateness of treatment for their pet including potential complications of surgery, potential outcomes, a comprehensive treatment plan, and associated costs with their veterinarian prior to treatment. A checklist of points for dog and cat owners to consider can be found here.